Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
SHAO Liang, HAN Zhen, WU Wan-chun, HE Chi-yi. Effect of garlicin on protecting nonalcoholic fat liver in SD rats induced by high fat diet[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(5): 571-574.
1 林青, 乔竞原.大蒜素的药理与临床应用[J].首都医药,2004 ;11:38-39. 2 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝病诊疗指南[J].中华肝脏病杂志, 2006;14:161-163. 3 刘玉兰.非酒精性脂肪肝的流行病学现状[J].胃肠病学,2003 ;8:361-363. 4 Shiva Kumar K, Peter F Malet.Nonalcoholic steatohepatitis[J].Mayo Clin Proc, 2000;75:73-79. 5 George DK, Goldwurm S, MacDonald GA, et al.Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis[J].Gastroenterology, 1998;114:311-318. 6 Day CP.Non-alcoholic steatohepatitis.Where are we now and where are we going[J] ? Gut, 2002;50:585-588. 7 Petersen KF, Oral EA, Dufour S, et al.Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy[J].J ClinInvest, 2002 ;109:1345. 8 Saleh MC, Wheeler MB, Chan CB.Uncoupling protein-2:evidence for its function as a metabolic regulator[J].Diabetologia,2002;45:174-187. 9 曾民德.脂肪肝发病机制及其“ 二次打击” 假设[J].中华消化杂志, 2002 ;22:167-168. 10 Diehl AM.Nonalcoholic steatohepatitis[J].Semin Liver Dis, 1999;19:221-229. 11 Wigg AJ, Roberts IC, Dymock RB, et al.The role of small intestimal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumor necrosis factor-a in the pathogenesis of nonalcoholisteatohepatitis[J].Gut, 2001 ;48:206-211. 12 赵龙凤, 贾军梅, 韩德五.肠源性内毒素血症在非酒精性脂肪性肝炎发病中的作用[J].中华肝脏病杂志, 2004;12:632.